NCCN Categories of Evidence and Consensus
Category 1: Based upon high-level evidence, there is uniform NCCN consensus that the intervention is appropriate.
Category 2A: Based upon lower-level evidence, there is uniform NCCN consensus that the intervention is appropriate.
Category 2B: Based upon lower-level evidence, there is NCCN consensus that the intervention is appropriate.
Category 3: Based upon any level of evidence, there is major NCCN disagreement that the intervention is appropriate.
All recommendations are category 2A unless otherwise noted.
Clinical trials: NCCN believes that the best management for any cancer patient is in a clinical trial. Participation in clinical trials is especially encouraged.
GillenwaterAMHesselACMorrisonWH. Merkel cell carcinoma of the head and neck: effect of surgical excision and radiation on recurrence and survival. Arch Otolaryngol Head Neck Surg2001;127:149–154.
Medina-FrancoHUristMMFiveashJ. Multimodality treatment of Merkel cell carcinoma: case series and literature review of 1024 cases. Ann Surg Oncol2001;8:204–208.
AllenPJBowneWBJaquesDP. Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clin Oncol2005;23:2300–2309.
BichakjianCKLoweLLaoCD. Merkel cell carcinoma: critical review with guidelines for multidisciplinary management. Cancer2007;110:1–12.
LemosBDStorerBEIyerJG. Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system. J Am Acad Dermatol2010;63:751–761.
RaoPBalzerBLLemosBD. Protocol for the examination of specimens from patients with merkel cell carcinoma of the skin. Arch Pathol Lab Med2010;134:341–344.
FieldsRCBusamKJChouJF. Recurrence and survival in patients undergoing sentinel lymph node biopsy for Merkel cell carcinoma: analysis of 153 patients from a single institution. Ann Surg Oncol2011;18:2529–2537.
SchwartzJLGriffithKALoweL. Features predicting sentinel lymph node positivity in Merkel cell carcinoma. J Clin Oncol2011;29:1036–1041.
PaulsonKGIyerJGTegederAR. Transcriptome-wide studies of merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival. J Clin Oncol2011;29:1539–1546.
FieldsRCBusamKJChouJF. Five hundred patients with merkel cell carcinoma evaluated at a single institution. Ann Surg2011;254:465–475.
CheukWKwanMYSusterSChanJK. Immunostaining for thyroid transcription factor 1 and cytokeratin 20 aids the distinction of small cell carcinoma from Merkel cell carcinoma, but not pulmonary from extrapulmonary small cell carcinomas. Arch Pathol Lab Med2001;125:228–231.
HanlyAJElgartGWJordaM. Analysis of thyroid transcription factor-1 and cytokeratin 20 separates merkel cell carcinoma from small cell carcinoma of lung. J Cutan Pathol2000;27:118–120.
GruberSBWilsonLD. Merkel cell carcinoma. In: MillerSJMaloneyME eds.: Cutaneous Oncology: Pathophysiology Diagnosis and Management. Malden, MA: Blackwell Science; 1998:710–721.
SivaSByrneKSeelM. 18F-FDG PET provides high-impact and powerful prognostic stratification in the staging of Merkel cell carcinoma: a 15-year institutional experience. J Nucl Med2013;54:1223–1229.
HawrylukEBO’ReganKNSheehyN. Positron emission tomography/computed tomography imaging in Merkel cell carcinoma: a study of 270 scans in 97 patients at the Dana-Farber/Brigham and Women’s Cancer Center. J Am Acad Dermatol2013;68:592–599.
TregliaGKakhkiVRGiovanellaLSadeghiR. Diagnostic performance of fluorine-18-fluorodeoxyglucose positron emission tomography in patients with Merkel cell carcinoma: a systematic review and meta-analysis. Am J Clin Dermatol2013;14:437–447.
SkeltonHGSmithKJHitchcockCL. Merkel cell carcinoma: analysis of clinical, histologic, and immunohistologic features of 132 cases with relation to survival. J Am Acad Dermatol1997;37:734–739.
FinniganRHrubyGWrattenC. The impact of preradiation residual disease volume on time to locoregional failure in cutaneous Merkel cell carcinoma: a TROG substudy. Int J Radiat Oncol Biol Phys2013;86:91–95.
BoyerJDZitelliJABrodlandDGD’AngeloG. Local control of primary Merkel cell carcinoma: review of 45 cases treated with Mohs micrographic surgery with and without adjuvant radiation. J Am Acad Dermatol2002;47:885–892.
O’ConnorWJRoenigkRKBrodlandDG. Merkel cell carcinoma: comparison of Mohs micrographic surgery and wide excision in eighty-six patients. Dermatol Surg1997;23:929–933.
PenningtonBELeffellDJ. Mohs micrographic surgery: established uses and emerging trends. Oncology (Williston Park)2005;19:1165–1171; discussion 1171-1172 1175.
GuptaSGWangLCPenasPF. Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma: the Dana-Farber experience and meta-analysis of the literature. Arch Dermatol2006;142:685–690.
Santamaria-BarriaJABolandGMYeapBY. Merkel cell carcinoma: 30-year experience from a single institution. Ann Surg Oncol2013;20:1365–1373.
WillisAIRidgeJA. Discordant lymphatic drainage patterns revealed by serial lymphoscintigraphy in cutaneous head and neck malignancies. Head Neck2007;29:979–985.
AllenPJBusamKHillAD. Immunohistochemical analysis of sentinel lymph nodes from patients with Merkel cell carcinoma. Cancer2001;92:1650–1655.
SuLDLoweLBradfordCR. Immunostaining for cytokeratin 20 improves detection of micrometastatic Merkel cell carcinoma in sentinel lymph nodes. J Am Acad Dermatol2002;46:661–666.
SchmalbachCELoweLTeknosTN. Reliability of sentinel lymph node biopsy for regional staging of head and neck Merkel cell carcinoma. Arch Otolaryngol Head Neck Surg2005;131:610–614.
RushZFieldsRCLeeNBrownellI. Radiation therapy in the management of Merkel cell carcinoma: current perspectives. Expert Rev Dermatol2011;6:395–404.
JouaryTLeyralCDrenoB. Adjuvant prophylactic regional radiotherapy versus observation in stage I Merkel cell carcinoma: a multicentric prospective randomized study. Ann Oncol2012;23:1074–1080.
MojicaPSmithDEllenhornJD. Adjuvant radiation therapy is associated with improved survival in Merkel cell carcinoma of the skin. J Clin Oncol2007;25:1043–1047.
GarneskiKMNghiemP. Merkel cell carcinoma adjuvant therapy: current data support radiation but not chemotherapy. J Am Acad Dermatol2007;57:166–169.
PoulsenMGRischinDPorterI. Does chemotherapy improve survival in high-risk stage I and II Merkel cell carcinoma of the skin?Int J Radiat Oncol Biol Phys2006;64:114–119.
PoulsenMRischinDWalpoleE. High-risk Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: a Trans-Tasman Radiation Oncology Group Study-TROG 96:07. J Clin Oncol2003;21:4371–4376.
TaiPTYuEWinquistE. Chemotherapy in neuroendocrine/Merkel cell carcinoma of the skin: case series and review of 204 cases. J Clin Oncol2000;18:2493–2499.
VoogEBironPMartinJPBlayJY. Chemotherapy for patients with locally advanced or metastatic Merkel cell carcinoma. Cancer1999;85:2589–2595.
PaulsonKGIyerJGBlomA. Systemic immune suppression predicts diminished Merkel cell carcinoma-specific survival independent of stage. J Invest Dermatol2013;133:642–646.